Co-founder of Emerald Cloud Lab and Emerald Therapeutics
Co-founder of Emerald Cloud Lab and Emerald Therapeutics
Brian M. Frezza serves as the lead architect of the Emerald Cloud Lab (ECL), a web-based platform for remotely conducting and managing data surrounding wet lab experiments, as well as spearheads Emerald Therapeutic's anti-viral research effort. Brian completed his PhD in Chemical Biology at The Scripps Research Institute (TSRI) working on DNA nanotechnology under committee mentorship of Feynman award-winning chemists M. Reza Ghadiri and Nadrian Seeman. Brian is a Hollerith and Wolfram Innovator award-winner who has received over four hundred combined citations for published articles in the Journal of the American Chemical Society (JACS) and Chemical Physics. He has also served as a peer reviewer for both JACS and Langmuir, and guest-lectured at Carnegie Mellon University, TSRI, and Stanford University.
Co-founder of Emerald Cloud Lab and Emerald Therapeutics
Co-founder of Emerald Cloud Lab and Emerald Therapeutics